A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer.

Socinski, Mark A

A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jun 2013 - 3068-77 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1557-3265

10.1158/1078-0432.CCR-12-3381 doi


Adult
Aged
Aged, 80 and over
Anaplastic Lymphoma Kinase
Antineoplastic Agents--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Female
Gene Rearrangement
Genotype
HSP90 Heat-Shock Proteins--antagonists & inhibitors
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Mutation
Neoplasm Staging
Receptor Protein-Tyrosine Kinases--genetics
Treatment Outcome
Triazoles--administration & dosage